ELMD Electromed, Inc.
Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1488917 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY14.1%
TTM net income YoY45.5%
TTM EPS YoY45.7%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR54.4%
Margins
Gross margin79.0%
Operating margin19.5%
Net margin15.8%
FCF margin11.5%
EBITDA margin20.6%
Returns
ROE24.5%
ROA20.8%
ROIC (approx.)34.3%
Asset turnover1.32x
Leverage & solvency
Liabilities / assets14.1%
Debt / equity0.00x
Current ratio7.19x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.83x
Accruals ratio3.6%
Payout ratio—
Capex / revenue1.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2026Q22025-12-31 | 2026Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $18.68M | $19.42M | $18.57M | $18.90M | $16.89M | $17.39M | $15.68M | $16.25M |
| Cost of revenue | $3.75M | $4.13M | $3.93M | $4.08M | $3.69M | $3.77M | $3.46M | $3.63M |
| Gross profit | $14.94M | $15.28M | $14.64M | $14.82M | $13.20M | $13.62M | $12.23M | $12.63M |
| R&D expense | $277,000 | $328,000 | $361,000 | $384,000 | $241,000 | $302,000 | $277,000 | $251,000 |
| SG&A expense | $11.17M | $11.13M | $10.52M | $10.81M | $10.29M | $10.28M | $9.81M | $9.83M |
| Operating income | $3.49M | $3.83M | $3.77M | $3.62M | $2.67M | $3.04M | $2.14M | $2.54M |
| Pretax income | $3.64M | $3.96M | $3.87M | $3.73M | $2.80M | $3.17M | $2.28M | $2.69M |
| Income tax | $876,000 | $560,000 | $863,000 | $968,000 | $668,000 | $971,000 | $391,000 | $726,000 |
| Net income | $2.76M | $3.40M | $3.00M | $2.76M | $2.14M | $2.20M | $1.89M | $1.97M |
| EBITDA | $3.71M | $4.05M | $3.98M | $3.83M | $2.88M | $3.42M | $2.39M | $2.75M |
| EPS (basic) | 0.33 | — | 0.37 | 0.33 | 0.26 | — | 0.22 | 0.23 |
| EPS (diluted) | 0.32 | — | 0.35 | 0.32 | 0.25 | — | 0.21 | 0.22 |
| Weighted avg. shares (diluted) | 8.76M | — | 8.65M | 8.69M | 8.68M | — | 8.97M | 8.95M |
| Banking | ||||||||
| Net interest income | — | — | — | — | — | — | — | $152,000 |
| Balance sheet | ||||||||
| Cash & equivalents | $15.88M | $20.45M | $16.98M | $13.79M | $14.11M | $15.29M | $15.24M | $16.23M |
| Receivables | $30.27M | $29.80M | $28.25M | $26.26M | $24.76M | $24.66M | $23.44M | $22.77M |
| Inventory | $3.81M | $3.68M | $3.29M | $3.46M | $3.77M | $3.30M | $2.97M | $3.08M |
| Current assets | $52.19M | $57.37M | $50.23M | $45.57M | $44.56M | $45.08M | $44.20M | $44.19M |
| PP&E, net | $5.17M | $5.21M | $5.21M | $5.22M | $4.98M | $4.71M | $4.81M | $5.22M |
| Intangibles | $379,000 | $379,000 | $354,000 | $387,000 | $389,000 | $371,000 | $588,000 | $609,000 |
| Total assets | $61.09M | $66.27M | $59.47M | $54.91M | $53.61M | $53.80M | $52.45M | $52.27M |
| Current liabilities | $7.26M | $12.22M | $10.23M | $9.38M | $8.76M | $10.47M | $8.51M | $8.67M |
| Total liabilities | $8.62M | $12.29M | $10.31M | $9.47M | $8.87M | $10.59M | $8.51M | $8.67M |
| Shareholders' equity | $52.47M | $53.98M | $49.17M | $45.44M | $44.74M | $43.21M | $43.94M | $43.60M |
| Shares outstanding | 8.24M | 8.37M | 8.28M | 8.28M | 8.36M | 8.35M | 8.51M | 8.56M |
| Cash flow statement | ||||||||
| Operating cash flow | $373,000 | $2.99M | $3.48M | $3.03M | $169,000 | $3.86M | $2.07M | $3.15M |
| Capital expenditure | $165,000 | $219,000 | $147,000 | $634,000 | $252,000 | $145,000 | -$153,000 | $233,000 |
| Free cash flow | $208,000 | $2.77M | $3.33M | $2.39M | -$83,000 | $3.71M | $2.23M | $2.92M |
| Investing cash flow | -$202,000 | -$223,000 | -$154,000 | -$656,000 | -$267,000 | -$157,000 | $146,000 | -$237,000 |
| Financing cash flow | -$4.75M | $694,000 | -$128,000 | -$2.69M | -$1.08M | -$3.65M | -$3.22M | -$543,000 |
| Depreciation & amortization | $217,000 | $226,000 | $215,000 | $213,000 | $214,000 | $376,000 | $249,000 | $212,000 |
| Stock-based compensation | $435,000 | $762,000 | $846,000 | $656,000 | $458,000 | $650,000 | $757,000 | $955,000 |
| Share buybacks | $4.33M | $0 | $152,000 | $2.76M | $1.00M | $3.67M | $1.79M | -$22,000 |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.